Results for "Prevention of Mother to Child Transmission"
MSH: What is your role at MSH? I am the Prevention of Mother-to-Child Transmission (PMTCT) Technical Advisor placed at the Ministry of Health (MOH) in Malawi.MSH: What is the situation in Malawi with respect to the AIDS epidemic? What are Malawi’s greatest challenges in tackling HIV & AIDS? Malawi is experiencing a severe epidemic. Since 1985, when the first AIDS case was diagnosed, HIV prevalence has increased significantly in the 15–49 age group. It rose to 16.2 percent in 1999, before coming down and stabilizing at around 12 percent in 2005.
In 2011, the Malawi Ministry of Health (MOH) implemented an innovative approach (called "Option B+"), in which all HIV-infected pregnant and breastfeeding women are eligible for lifelong antiretroviral therapy (ART) regardless of CD4 count. Since that time, several countries have adopted the Option B+ policy. Using data collected through routine program supervision, this report is the first to summarize Malawi's experience implementing Option B+ under the direction of the MOH and supported by the Office of the Global AIDS Coordinator through the President's Emergency Plan for AIDS Relief (PEPFAR). In Malawi, the number of pregnant and breastfeeding women started on ART per quarter increased by 748%, from 1,257 in the second quarter of 2011 (before Option B+ implementation) to 10,663 in the third quarter of 2012 (1 year after implementation). Of the 2,949 women who started ART under Option B+ in the third quarter of 2011 and did not transfer care, 2,267 (77%) continue to receive ART at 12 months; this retention rate is similar to the rate for all adults in the national program. Option B+ is an important innovation that could accelerate progress in Malawi and other countries toward the goal of eliminating mother-to-child transmission of HIV worldwide.
Prevention of mother-to-child transmission of HIV (PMTCT) programs can greatly reduce the vertical transmission rate (VTR) of HIV, and Malawi is expanding PMTCT access by offering HIV-infected pregnant women life-long antiretroviral therapy (Option B+). There is currently no empirical data on the effectiveness of Malawian PMTCT programs. This study describes a surveillance approach to obtain population-based estimates of the VTR of infants
A new and more expansive agenda must be articulated to ensure that those infants and children who will never feel the impact of the current elimination agenda are reached and linked to appropriate care and treatment. This agenda must addresses challenges around both reducing vertical transmission through PMTCT and ensuring access to appropriate HIV testing, care, and treatment for all affected children who were never able to access PMTCT programming. Option B+, or universal test and treat for HIV-infected pregnant women, is an excellent start, but it may be time to rethink our current approaches to delivering PMTCT services. New strategies will reduce vertical transmission to less than 1% for those mother-infant pairs who can access them allowing for the contemplation of not just PMTCT, but actual elimination of MTCT. But expanded thinking is needed to ensure elimination of pediatric HIV.
This post originally appeared on USAID’s IMPACT blog. USAID is observing World AIDS Day this year by celebrating ten years of HIV and AIDS work under PEPFAR. More than 85,000 infants in Nigeria are at risk of HIV transmission from their mothers every year. While the number of HIV-positive pregnant women who receive antiretroviral treatment (ART) is increasing, robust efforts to improve coverage are needed if national targets (PDF) for prevention of mother-to-child transmission of HIV (PMTCT) are to be met in 2015.
A new study published in PLOS ONE offers a potentially easy and cost-effective strategy for evaluating the efficacy of Malawi’s Option B+ Prevention of Mother-to-Child Transmission of HIV (PMTCT) program. The study describes a surveillance approach to obtain population-based estimates of the vertical transmission rate (VTR) of infants exposed to HIV from their mothers in Malawi immediately after the adoption of the Option B+ strategy.
The WHO 2010 guidelines specify that a CD4 cell count is crucial to decisions about the eligibility of HIV-infected pregnant women for lifelong antiretroviral treatment (ART). In Malawi, however, access to CD4 cell count analysis is minimal. Thus, to make this test a prerequisite for increasing the coverage of prevention of mother-to-child transmission services and early access to ART would hinder rapid expansion in countries with heavily constrained health systems.
Background: Mother-to-child transmission of HIV (MTCT) remains the most prevalent source of pediatric HIV infection. Most PMTCT (prevention of mother-to-child transmission of HIV) programs have concentrated monitoring and evaluation efforts on process rather than on outcome indicators. In this paper, we review service data from 28,320 children born to HIV-positive mothers to estimate MTCT rates. Method: This study analyzed DNA PCR results and PMTCT data from perinatally exposed children zero to 12 months of age from five Zambian provinces between September 2007 and July 2010.
Mbeere District Hospital, following USAID-funded LMS/Kenya support, increases the number of HIV-positive mothers delivering healthy babies According to the Ministry of Health, 13,000 babies in Kenya are born HIV-positive each year, despite availability of proven methods to prevent mother-to-child transmission of the virus. One of these is integrating HIV care and treatment into maternal and child health services. In 2013, Mbeere District Hospital in Embu County decided to take this approach to reduce the number of children born with HIV in their facility.
Management Sciences for Health and mothers2mothers International invite you to attend a Senate briefing and reception as representatives of the non-profit, government, corporate, and African HIV community present:The Elimination of New HIV Infections in Children by 2015 and Keeping Mothers Alive: A Call to ActionEach year millions of children in the developing world are born to mothers living with HIV. Without intervention, as many as 40 percent of these mothers will transmit the virus to their newborns. Yet mother-to-child transmission of HIV/AIDS is almost entirely preventable.